Laboratory Products

  • New Clinical MDR and Study Automation Platform Accelerates Clinical Trial Design and Build
    ryze accelerates and streamlines the design, build and submission of clinical trials.

New Clinical MDR and Study Automation Platform Accelerates Clinical Trial Design and Build

Apr 08 2021 Read 15 Times

Formedix announces the launch of ryze, an innovative all-in-one cloud-based clinical metadata repository (MDR) and study automation platform. ryze has been specifically developed to accelerate and streamline the design, build and submission of clinical trials, in compliance with the Clinical Data Interchange Standards Consortium (CDISC) and NCI Controlled Terminology.

As a fully-integrated software suite, ryze enables the design and build of the full spectrum of case report forms (CRFs), study data tabulation models (SDTMs) and analysis data models (ADaMs), while also automating SDTM mappings and conversions. Built with compliance at its core, the platform features metadata templates with embedded CDISC standards and NCI Controlled Terminology. This enables pharmaceutical, biotechnology and CRO organisations to effortlessly meet their regulatory objectives. Importantly, ryze facilitates metadata standardisation, expediting clinical trial set up, enabling data reuse, and improving data quality and consistency.

“Time is of the essence when it comes to clinical trials,” explained Kevin Burges, Head of Product Management at Formedix. “Designing and managing metadata in accordance with stringent regulatory requirements can significantly delay the whole process. Over recent decades, these challenges have triggered a notable shift from manual, labour-intensive paper-based clinical trial set-up processes to digitised approaches that can help pharmaceutical, biotechnology and CRO organisations with their strive to make a difference to patients’ lives. As an all-in-one cloud-based platform, ryze simplifies end-to-end metadata management and fosters cross-collaboration between stakeholders. Ultimately, the platform provides significant time and cost savings, facilitating faster delivery of new therapies.”

ryze is the only platform that allows seamless integration with a wide selection of leading electronic data capture (EDC) systems, including support for the individual functionality of each system. As such, clinical data professionals can use ryze to design CRFs and make any necessary changes before automatically exporting the designs into the EDC of their choice to build their clinical trial. As a result, clinical trial build can take as little as 6 weeks.

Furthermore, ryze is a commercial off-the-shelf system, meaning it is available for use immediately and can be rapidly configured to meet specific application needs. 

SDTM conversion is enabled at the click of a button, significantly reducing time-to-data and providing clinicians instant visibility of patient data as soon as it starts flowing in from the EDC system. This allows clinicians to gain actionable data insights to drive well-informed, data-based decision making. Owing to this unique capability, an early release of ryze has already been used with great success to rapidly roll-out COVID-19 vaccine clinical trials. 

More information online

Digital Edition

Labmate UK & Ireland April2021

April 2021

In This Edition Articles - Seats at the table to shape the industry’s future - Battling biohazardous liquid laboratory waste Laboratory Products - Two New Powerful Stirrers Announced...

View all digital editions


ChemBio Finland - Virtual preview

Apr 28 2021 Virtual event

SETAC Europe

May 02 2021 Virtual conference

AOCS Annual Meeting & Expo

May 03 2021 Online event


May 09 2021 Fort Worth, Tx, USA

View all events